• S&P 500: 1,337.97
  • Change: -1.03%
$20.30 0.04 (+0.20%)
2/10/2012 10:07 AM

ICON plc (ADR) (NASDAQ:ICLR)

CAPS Rating: 4 out of 5

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

Current Price $20.30 Mkt Cap $1.23B
Open $20.30 P/E Ratio 14.70
Prev. Close $20.26 Div. (Yield) N/A (N/A)
Daily Range $20.22 - $20.38 Volume 64,629
52-Wk Range $15.03 - $26.22 Avg. Daily Vol. 0

Caps

How do you think ICLR will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

361 Outperform
8 Underperform
 

All-Star Players

120 Outperform
0 Underperform
 

Wall Street

6 Outperform
1 Underperform
 

Top ICLR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

dollarpimp (68.88)
Submitted January 19, 2008

Discounted earnings valuation assuming 25% earnings growth over 10 years indicates this stock is selling at a substantial discount. Even assuming 20%, it's fairly priced. Just backed off a new high, buying on the dip. Healthcare sector will… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

ICLR VS S&P 500 (SPY)

Fools bullish on ICLR are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ICLR.

Recs

0
Member Avatar velo15 (< 20) Submitted: 10/26/2011 3:33:39 PM : Outperform Start Price: $15.76 ICLR Score: +20.93

bought this and IRE IRL this past week, ND fans are everywhere, go Irish!!!

Recs

0
Member Avatar TMFRisingStars (53.61) Submitted: 7/29/2011 10:21:20 AM : Outperform Start Price: $22.28 ICLR Score: -12.62

Here's the buy rec:
http://www.fool.com/investing/general/2011/07/27/rising-stars-buy-icon.aspx

Recs

0
Member Avatar RENNOTA (< 20) Submitted: 10/15/2010 12:45:04 PM : Outperform Start Price: $21.19 ICLR Score: -18.19

True to my style, this stock has all the makings of a security whose price understates the value of the underlying business. This company produces some pretty impressive margins, while still maintaining a very healthy balance sheet. The firm also sticks to its core competencies beautifully, indicating a disciplined, intelligent management.
I also like this stock because, in addition to currently looking attractive, it incorporates a larger, macro play. It stands to grow revenue as pharmaceutical companies increasingly outsource their testing operations in an effort to cut costs. I think this stock appears poised to outperform the broad market index.

Leaderboard

Find the members with the highest scoring picks in ICLR.

Score Leader

ll0o0ll

ll0o0ll (99.09) Score: +109.01

The Score Leader is the player with the highest score across all their picks in ICLR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Bankwatcher1 < 20 10/7/2008 Underperform NS $36.90 -44.96% +30.30% +75.26 0 Comment
lapythemarvelous 77.43 10/6/2008 Underperform 3W $36.02 -43.61% +28.47% +72.08 0 Comment
tamitho < 20 6/23/2008 Underperform 3M $37.50 -45.84% +4.81% +50.65 0 Comment
bastiphan 25.83 1/5/2009 Underperform 3W $19.24 +5.56% +46.83% +41.27 0 Comment
cveezy28 67.28 4/24/2008 Underperform 1Y $32.45 -37.41% +1.52% +38.94 0 Comment
Seth157018192 89.21 10/11/2011 Outperform NS $15.15 +34.06% +12.30% +21.76 0 Comment
eloucks 92.72 10/25/2011 Outperform 1Y $15.77 +28.79% +7.43% +21.36 0 Comment
velo15 < 20 10/26/2011 Outperform 5Y $15.76 +28.87% +7.94% +20.93 1 Comment
hanktmoon 64.79 10/20/2011 Outperform 5Y $15.55 +30.61% +10.16% +20.45 0 Comment
TMFHelical 98.34 10/25/2011 Outperform 5Y $15.91 +27.66% +8.69% +18.96 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackStandpoint 97.07 10/25/2010 Outperform NS $19.80 +0.91% +10.23% -9.32 2/24/2011 @ $19.98 0 Comment
TrackGoldmanSach 71.46 3/17/2010 Outperform 5Y $24.82 +9.39% -5.35% +14.74 7/26/2010 @ $27.15 1 Comment
TrackJPMorgan < 20 7/16/2009 Outperform NS $23.28 +25.30% +27.74% -2.44 4/30/2010 @ $29.17 0 Comment
TrackDeutscheSec 90.34 5/13/2009 Outperform NS $15.65 +10.03% +42.08% -32.05 1/4/2012 @ $17.22 0 Comment
TrackJimCramer 78.06 5/5/2009 Underperform 3W $15.25 +33.18% +49.69% +16.51 0 Comment
TrackBarclaysCap 93.31 1/8/2009 Outperform NS $20.08 +1.15% +51.26% -50.11 0 Comment
TrackLadenburg 81.42 10/21/2008 Outperform NS $33.65 -46.51% -13.29% -33.21 4/16/2009 @ $18.00 0 Comment
TrackUBS 93.29 1/11/2008 Outperform NS $33.67 -39.68% -0.68% -39.00 0 Comment
TrackWellsFargo 92.46 11/28/2007 Outperform NS $28.76 -29.39% -2.51% -26.88 0 Comment
TrackJefferies 84.57 10/15/2007 Outperform NS $27.86 -27.10% -10.05% -17.05 0 Comment
TrackEveillard 95.98 9/30/2007 Outperform NS $25.51 -20.40% -7.87% -12.53 1 Comment
TrackLehmanBros 86.33 10/30/2006 Outperform NS $18.50 +9.81% +3.49% +6.32 0 Comment

Featured Broker Partners